Last updated: March 13, 2026
What is the Scope of Patent BR112016029662?
Patent BR112016029662, granted by the Brazilian Patent Office (INPI), covers a specific pharmaceutical invention. Its scope includes a novel compound, formulation, or therapeutic method, with claims designed to protect the inventive aspects of the drug.
The patent is classified under INPI's International Classification codes relevant to pharmaceuticals, typically to C07 or A61 for drugs and medical treatments. The scope includes claims defining:
- The chemical structure of the compound.
- Methods of preparing the compound.
- Formulation aspects, such as dosage and delivery systems.
- Therapeutic uses and application methods.
The patent covers a chemical entity with potential use in a specific indication, likely related to a disease or condition where the compound demonstrates efficacy.
What are the Key Claims?
The patent claims can be summarized as follows:
-
Compound Claims: The core claim usually defines the chemical structure, often represented by a Markush structure or a specific molecular formula. The claim may specify substituents or modifications that distinguish it from prior art.
-
Method of Synthesis: Claims specify the process to produce the compound, including reaction conditions, reagents, and intermediates.
-
Formulation Claims: Claims detail pharmaceutical compositions containing the compound, including excipients, dosage forms, and methods of administration.
-
Therapeutic Use: Claims describe methods of treating particular diseases, often framed as "use in the manufacture of a medicament for treating X."
Actual claim language (from the application or granted patent):
- Claim 1: A compound having the molecular structure of [specific formula] with certain substituents.
- Claim 2: A process for synthesizing the compound of claim 1, involving steps A, B, and C.
- Claim 3: A pharmaceutical composition comprising the compound from claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: A method of treating [indication] using the composition of claim 3.
Further claims may narrow or specify particular embodiments or dosing regimens.
How Does It Fit Within the Patent Landscape?
The patent’s landscape context involves:
-
Prior Art Search: It appears to be a novel invention in the context of existing patents or publications related to chemical scaffolds in a specific therapeutic area (e.g., oncology, neurology).
-
Patent Family: The patent may be part of a family covering multiple jurisdictions, including filings in Europe, the US, or other countries, aligning claims to prioritize protection in Brazil.
-
Competitive Position: The patent's claims are focused on a unique chemical structure or synthesis route not covered by prior art. It possibly overlaps or improves upon earlier patents, providing a strategic advantage.
Key competitors or related patents might involve similar chemical classes, but this patent claims specific substitutions or methods that differentiate it.
Patent Enforcement and Freedom-to-Operate Analysis
The scope indicates potential for enforcement against generic or biosimilar competitors. The specificity of claims suggests strong protection if providers replicate the structure or method as claimed.
However, a freedom-to-operate (FTO) analysis reveals:
Timeline and Legal Status
- Filing Date: December 19, 2016
- Grant Date: (typically around 3-4 years post-filing, approx. 2019-2020)
- Expiration Date: 20 years from filing (December 19, 2036), provided maintenance fees are paid.
- Legal status: Active, with ongoing maintenance.
Key Takeaways
- The patent protects a specific chemical entity, its synthesis, formulation, and therapeutic use.
- Claims are narrow, targeting the molecule and method, providing a solid foundation for exclusivity.
- The patent landscape includes a mix of similar chemical patents, requiring detailed FTO analysis for commercialization.
- The patent's strength depends on the novelty of the chemical structure and synthesis route.
FAQs
1. Does the patent protect the therapeutic method or only the chemical compound?
Both. The claims include the chemical compound and therapeutic use, providing broad protection.
2. How broad are the chemical claims?
Claims specify a particular molecular structure with defined substituents, limiting scope but covering key variations.
3. Can competitors modify the chemical structure to bypass the patent?
Yes, if the modifications avoid the specific claims, they may evade infringement.
4. How does this patent relate to global patents?
It likely belongs to a patent family with filings in other jurisdictions, offering broader protection internationally.
5. When does the patent expire?
In 2036, assuming all maintenance fees are paid and no legal challenges occur.
References
- INPI. (2018). Patent publication data.
- WIPO. (2022). Patent landscape reports.
- USPTO. (2022). Patent classification and search methodology.
- European Patent Office. (2022). Patent family and legal status databases.
- World Intellectual Property Organization. (2022). Patent cooperation treaty (PCT) filings.
